Related Experiment Video
Updated: Jan 7, 2026
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
Modulating ACVRL1 Expression in HMEC1 Cells as a Simplified In Vitro Model for Hereditary Hemorrhagic Telangiectasia
Johanna R Rusche1, Michael Bette2, Boris A Stuck1
1VASCERN HHT Reference Center and Interdisciplinary Center for Vascular Anomalies, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Giessen and Marburg, Campus Marburg, and Philipps-Universität Marburg, Marburg, Germany.
Hereditary hemorrhagic telangiectasia (HHT) is a rare vascular disorder. Knocking down the ACVRL1 gene in endothelial cells created a model for HHT2, showing abnormal blood vessel formation.
Area of Science:
- Vascular Biology
- Genetics
- Cell Biology
Background:
- Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disorder affecting blood vessels.
- HHT is linked to mutations in genes like ACVRL1 (HHT2) and ENG (HHT1).
- Patients commonly experience recurrent nosebleeds due to vascular malformations.
Purpose of the Study:
- To investigate if ACVRL1 gene knockdown in HMEC-1 cells mimics HHT2.
- To establish an in vitro model for studying HHT2.
Main Methods:
- RNA interference (RNAi) was used to knock down ACVRL1 in HMEC-1 cells.
- Gene knockdown was confirmed via RT-qPCR and Western blot.
- Tube formation assays and RT-qPCR analyzed angiogenesis and gene expression changes.
Main Results:
- ACVRL1 knockdown significantly altered tube formation, increasing total length and mesh area while decreasing branching and junction numbers.
- Significant changes in angiogenesis-related gene expression were observed.
- The results indicate pathological angiogenesis.
Conclusions:
- ACVRL1 knockdown in HMEC-1 cells induces pathological angiogenesis resembling HHT2.
- This cell-based system shows potential as an in vitro model for HHT2 research.
